Metastatic (stage 4) esophageal cancer

Request an Appointment

Stages

Stage 4 esophageal cancer is divided into stage 4A and stage 4B based on how far the cancer has spread.

  • Stage 4A. The cancer has spread extensively in or through the esophagus or to many nearby lymph nodes. It has not spread to distant organs.
  • Stage 4B. The cancer has spread to distant parts of the body, such as the liver or lungs.

The stage is one factor the healthcare team uses to plan treatment. Other factors include the type of esophageal cancer, overall health and results of tests on the tumor.

For stage 4A, treatment may focus on the cancer in and around the esophagus. Treatment may include chemotherapy, radiation therapy and sometimes surgery.

For stage 4B, treatment usually focuses on slowing or controlling cancer throughout the body, helping people live longer and relieving symptoms. Treatment may include chemotherapy, immunotherapy, targeted therapy, radiation therapy and supportive care. Surgery usually is not used for widespread metastatic disease.

Request an appointment
Diagnosis & treatmentSurvival rates
Sept. 24, 2026
  1. Ajani JA, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023; doi:10.6004/jnccn.2023.0019.
  2. Li S, et al. Clinical features, treatment and prognosis analysis of distant metastatic esophageal cancer. Scientific Reports. 2025; doi:10.1038/s41598-025-16890-w.
  3. Akumaga T, et al. Targeting esophageal cancer: Promising drugs for the clinical landscape and key knowledge gaps. Drug Design, Development and Therapy. 2026; doi:10.2147/DDDT.S543686.
  4. Metges JP, et al. Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study. ESMO Open. 2025; doi:10.1016/j.esmoop.2025.105854.
  5. Shah MA, et al. Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO living guideline, version 2026.1.2. Journal of Clinical Oncology. 2026; doi:10.1200/JCO-26-01944.
  6. Kato K, et al. Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648. Annals of Oncology. 2026; doi:10.1016/j.annonc.2026.08.001.
  7. Soliman YY, et al. Endoscopic palliative therapies for esophageal cancer. Gastrointestinal Endoscopy Clinics of North America. 2024; doi:10.1016/j.giec.2023.07.003.
  8. Esophageal cancer. National Cancer Institute. https://www.cancer.gov/types/esophageal. Accessed Sept. 8, 2026.
  9. Noronha V, et al. Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer. International Journal of Cancer. 2024; doi:10.1002/ijc.35111.
  10. Surveillance, Epidemiology, and End Results Program. SEER*Explorer: Esophagus relative survival rates by time since diagnosis, distant stage. National Cancer Institute. https://seer.cancer.gov/statistics-network/explorer. Accessed Sept. 8, 2026.
  11. Pan L, et al. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: A SEER database analysis. Chinese Clinical Oncology. 2024; doi:10.21037/cco-23-88.
  12. Kroese TE, et al. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4). European Journal of Cancer. 2024; doi:10.1016/j.ejca.2024.114062.
  13. Guo X, et al. Survival outcomes and prognostic factors of early-onset and late-onset metastatic esophageal cancer: A population-based study. Scientific Reports. 2025; doi:10.1038/s41598-025-08618-7.
  14. Last Days of Life (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning/last-days-hp-pdq. Accessed Sept. 8, 2026.
  15. Obermannová RL, et al. ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma. ESMO Open. 2025; doi:10.1016/j.esmoop.2025.104134.
  16. Zhou P, et al. Efficacy and safety in proton therapy and photon therapy for patients with esophageal cancer: A meta-analysis. JAMA Network Open. 2023; doi:10.1001/jamanetworkopen.2023.28136.
  17. Metastatic cancer: When cancer spreads. National Cancer Institute. https://www.cancer.gov/types/metastatic-cancer. Accessed Aug. 27, 2026.
  18. Last days of life (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning/last-days-hp-pdq. Accessed Aug. 27, 2026.
  19. Strickland MR, et al. Initial systemic therapy for metastatic esophageal and gastric cancer. https://www.uptodate.com/contents/search. Accessed Aug. 28, 2026.
  20. Medical review (expert opinion). Mayo Clinic. Sept. 11, 2026.

Related

Associated Procedures

Metastatic (stage 4) esophageal cancer